Citigroup Inc Stevanato Group S.P.A. Transaction History

Citigroup Inc

$190 Billion
Q1 2025

A detailed history of Citigroup Inc transactions in Stevanato Group S.P.A. stock. As of the latest transaction made, Citigroup Inc holds 6,228 shares of STVN stock, worth $154,454. This represents 0.0% of its overall portfolio holdings.

Number of Shares

6,228

Previous 10,805 42.36%

Holding current value

$154,454

Previous $235,000 45.96%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 12, 2025	SELL	$18.11 - $24.11 $82,889 - $110,351	-4,577 Reduced 42.36%	6,228 $127,000
Q4 2024 Feb 12, 2025	SELL	$17.27 - $23.67 $26,803 - $36,735	-1,552 Reduced 12.56%	10,805 $235,000
Q3 2024 Nov 12, 2024	SELL	$17.98 - $22.02 $27,976 - $34,263	-1,556 Reduced 11.18%	12,357 $247,000
Q2 2024 Aug 12, 2024	SELL	$16.93 - $31.33 $29,847 - $55,234	-1,763 Reduced 11.25%	13,913 $255,000
Q1 2024 May 10, 2024	BUY	$25.34 - $34.28 $397,052 - $537,133	15,669 Added 223842.86%	15,676 $503,000
Q3 2023 Nov 09, 2023	SELL	$26.91 - $35.49 $17,276 - $22,784	-642 Reduced 98.92%	7 $0
Q2 2023 Aug 10, 2023	SELL	$25.15 - $32.86 $17,076 - $22,311	-679 Reduced 51.13%	649 $21,000
Q1 2023 May 11, 2023	SELL	$17.5 - $25.9 $560 - $828	-32 Reduced 2.35%	1,328 $34,000
Q4 2022 Feb 09, 2023	SELL	$13.95 - $19.28 $12,666 - $17,506	-908 Reduced 40.04%	1,360 $24,000
Q3 2022 Nov 10, 2022	BUY	$14.66 - $18.3 $7,843 - $9,790	535 Added 30.87%	2,268 $38,000
Q2 2022 Aug 10, 2022	BUY	$14.1 - $20.26 $24,040 - $34,543	1,705 Added 6089.29%	1,733 $27,000
Q4 2021 Feb 10, 2022	BUY	$21.65 - $27.0 $606 - $756	28 New	28 $1,000

Others Institutions Holding STVN

# of Institutions

146

Shares Held

53.7M

Call Options Held

Put Options Held

View Full List

About Stevanato Group S.p.A.

Ticker STVN
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 264,700,000
Market Cap $6.56B
Description
Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for pharma and healthcare. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machine...

More about STVN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account